RNA as Cancer Drivers, Biomarkers and Therapeutics
Bethesda, Maryland 20892
Building 35
Room 620/630/640
The NCI RNA Biology Initiative aims to facilitate the rapid exchange of information and expertise on the structure, function, biological roles, and therapeutic uses of RNA. Our goal is to foster synergistic interactions amongst NIH investigators and between NIH investigators and the larger scientific community. We anticipate that new insights into RNA biology and the development of innovative RNA-based tools and therapies will both define novel targets and accelerate the implementation of therapeutic interventions in cancer.
This one-day workshop will bring together leaders from industry, academia, and government with expertise in therapeutic oligonucleotides, delivery, small molecules, and preclinical development of novel RNA-based and RNA-targeted therapies.
Speakers:
- Olga Anczukȯw, Ph.D., The Jackson Laboratory for Genomic Medicine
- Vinod Balachandran, M.D., Memorial Sloan Kettering Cancer Center
- Nadya Dimitrova, Ph.D., Yale University
- Frank Slack, Ph.D., Beth Israel Deaconess Medical Center
- Sohail Tavazoie, M.D., Ph.D., Rockefeller University
There is no registration fee, but those who are not a U.S. citizen or do not possess a U.S.-issued Green Card, must pre-register at least 30 days prior to the conference to gain in-person access to NIH campus. More information can be found under the Security tab.